Mark Elban

Title: Mark Elban: Innovator in Hydroxy Formamide Derivatives

Introduction

Mark Elban is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of chemistry, particularly with his work on hydroxy formamide derivatives. His innovative approach has led to the development of compounds that have potential therapeutic applications.

Latest Patents

Mark Elban holds a patent for "Hydroxy formamide derivatives and their use." This patent discloses compounds characterized by a specific formula, where R1, R2, and R3 are defined within the document. The compounds are noted for their utility as inhibitors of BMP1, TLL1, and/or TLL2, which are associated with various diseases. This patent highlights the importance of his work in addressing health issues linked to these activities.

Career Highlights

Mark Elban is affiliated with GlaxoSmithKline Intellectual Property (No. 2) Limited, where he continues to advance his research and development efforts. His career is marked by a commitment to innovation and the application of scientific principles to real-world problems.

Collaborations

Mark has collaborated with esteemed colleagues, including Sarah E. Dowdell and Hilary Schenck Eidam. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Mark Elban's contributions to the field of chemistry, particularly through his patent on hydroxy formamide derivatives, demonstrate his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in therapeutic applications.